Multiple forms of DNA-dependent RNA polymerase (EC 2.7.7.6 ) have been demonstrated in eukaryotic cells (Roeder & Rutter, 1969; Jacob et al., 1970a; Kedinger et al., 1970; Mondal et al., 1970; Horgen & Griffin, 1971; Strain et al., 1971) . RNA polymerase I (or A), which is associated with the nucleolus , is probably engaged in the transcription of nucleolar genes to form rRNA (Blatti et al., 1970; Tocchini-Valentini & Crippa, 1970; Zylber & Penman, 1971) , whereas RNA polymerase II (or B) , which is present in the nucleoplasmic fraction (Roeder & Rutter, 1970a) , is probably making extranucleolar nuclear RNA, including heterogeneous nRNA and mRNA (Blatti et al., 1970; Tocchini-Valentini & Crippa, 1970) .
Selective inhibitors of RNA synthesis catalysed by these enzymes and of each step of the RNA polymerase reaction would be useful in exploring the mechanism of RNA synthesis in nucleated cells.
ac-Amanitin is a potent and specific inhibitor of nucleoplasmic RNA polymerase (Jacob et al., 1970a; Kedinger et al., 1970; Blatti et al., 1970; Lindel et al., 1970) , affecting the elongation step Lindel et al., 1970; Jacob et al., 1970b) .
The activity of mitochondrial RNA polymerase is selectively inhibited by rifampicin and rifamycin (Shmerling, 1969; Reid &Parsons, 1971) , which are inhibitors of prokaryotic RNA polymerase (Hartmann et al., 1967; Wehrli et al., 1968) at the initiation step (Wehrli et al., 1968; Sippel & Hartmann, 1968) . Also, Butterworth et al. (1971) have reported the effect of a rifamycin analogue on the transcription of mammalian chromatin by mammalian DNAdependent RNA polymerase. Horgen & Griffin (1971) reported that cycloheximide inhibited specifically nucleolar RNA polymerase (polymerase I) of Blastocladiella emersonii. However, the activity of RNA polymerase solubilized from the nucleoli of rat liver was not affected by cycloheximide even at a concentration as high as 1 mg/ml .
In the course of screening drugs that may affect RNA polymerase we have investigated several rifamycin derivatives including rifamide, the O-octyloxime of 3-formylrifamycin SV (compound AF/013) and 4-N-benzyl -2,5 -dimethyldemethylrifampicin (compound AF/ABDMP). The present paper shows that compounds AF/ABDMP and AF/013 inhibit Vol. 128 the soluble DNA-dependent RNA polymerases I and II of rat liver. These drugs seem to inhibit the RNA polymerase activities at a step prior to polymerization of ribonucleotides, possibly as a result of interaction with the RNA polymerase molecules.
Materials and methods
Rifampicin, rifamide and compounds AF/ABDMP and AF/013 were kindly supplied by Lepetit Pharmaceuticals Ltd. (Maidenhead, Berks., U.K.).
[14C]UTP (5OmCi/mmol) was purchased from The Radiochemical Centre (Amersham, Bucks., U.K.).
The nucleolar and extranucleolar nuclear fractions were obtained by a modification ) of the sonication procedure described by Muramatsu (1970) , with Mg2" instead of Ca2+. The nucleolar and extranucleolar nuclear RNA polymerases were purified from these fractions by (NH4)2SO4 precipitation followed by column chromatography on DEAE-Sephadex A-25 by the procedure described by Roeder & Rutter (1969 , 1970 . RNA polymerases I and II were each eluted as single peaks, at 0.15M-and 0.25M-(NH4)2SO4 respectively. The eluate was stored at -70°C after the addition of bovine serum albumin (final concn. lmg/ml). The standard reaction mixture for the assay of RNA polymerase activity contained, in 0. .) The final salt concentrations of the reaction mixture were 0.03 M and 0.1 M with respect to (NH4)2SO4 for RNA polymerases I and II respectively. Mn2+ was used throughout, since even RNA polymerase I was more active with this ion than with Mg2+ (Roeder & Rutter, 1969) .
After incubation of the mixture for 10min at 37°C, a 0.1 ml portion was delivered on to a glass-fibre disc (Whatman GF/C), which was then immersed in ice-cold 5 % (w/v) trichloroacetic acid-1 % (w/v) sodium pyrophosphate for 15min. The discs were washed four times by resuspension in the same medium (5min each time) and finally once by immersion in ethanol for 10min. Radioactivity was determined in toluene scintillation fluid in a Packard Tri-Carb liquid-scintillation spectrometer.
Results and discussion
In agreement with observations with calf thymus RNA polymerases (Chambon etal., 1970) , rifampicin had little inhibitory effect on the activity of either of the two enzymes from rat liver, even at a concentration of 500Sug/ml (Fig. la) . Rifamide at 500,ug/ml inhibited each RNA polymerase activity by only 20 % (Fig. Ib) 2(c) and 2(d), transcription by RNA polymerase II was not inhibited by compound AF/013 or by compound AF/ABDMP when either was added to the reaction mixture after RNA synthesis was already initiated. These results indicate that these drugs inhibit RNA synthesis at a step before elongation. With RNA polymerase I, however, partial inhibition was noted when the drugs were added to the assay mixture even after RNA synthesis was initiated (Figs.  2a and 2b) . This partial and progressive inhibition may be explained in either one of two ways, under the assumption that these drugs inhibit initiation only: (1) RNA polymerase I may be able to initiate RNA synthesis at restricted regions on the DNA template, so that re-initiation occurs more frequently in this system than with RNA polymerase II; (2) with RNA polymerase I formation of the enzyme-DNA complex or initiation might take place more slowly than with RNA polymerase II in our system. Another explanation, namely that only RNA polymerase I could be influenced partially at the elongation step, cannot be completely ruled out, although it is not very likely.
Actinomycin D, which binds with DNA and inhibits RNA synthesis mostly at the step ofelongation, was in fact effective irrespective ofthe time ofaddition of the drug (Fig. 2a) . Concn. of drug (uXg/ml) Fig. 1 . Effect of rifamycin derivatives on soluble DNA-dependent RNA polymerase activities from rat liver Experimental details are as described under 'Materials and methods'. Drugs were dissolved in dimethyl sulphoxide. In the control, the assay was carried out in the presence of the same final concentration of dimethyl sulphoxide (6.6%, v/v) Crippa & Tocchini-Valentini (1971) and Ficq & Brachet (1971) have suggested a possible role of RNA-dependent DNA polymerase in the amplification of ribosomal genes during the early oogenesis of Xenopus laevis. Their conclusion is at least partly based on the specificity of the action of compound AF/ABDMP on this enzyme. It is particularly noteworthy that transcription in both directions (DNA-* RNA and RNA-*DNA) is inhibited by the same drug, compound AF/ABDMP, with respect to ribosomal genes. This may help to shed some light on the mechanism of these apparently opposite but related reactions.
